Guyer William

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$3.29M

Insider Activity of Guyer William

According to the SEC Form 4 filings, Guyer William, being in a position of

  1. Chief Development Officer at Corcept Therapeutics Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 83394 shares for $2.97M,
    over all time since 2023-12-22, has bought 0 shares, and sold 93394 shares for $3.29M.

The largest sale of all time was on 2024-05-28 and amounted to 30000 shares of Corcept Therapeutics Incorporated for $960,000.

Biography of Guyer William

No biography is available at this moment.

2024-11-04SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
3,394
0.0032%
$48.97$166,204+15.33%
2024-10-01SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
10,000
0.0102%
$46.28$462,800+16.15%
2024-09-03SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
10,000
0.0099%
$35.30$353,000+42.94%
2024-08-01SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
10,000
0.0098%
$38.67$386,700+21.09%
2024-07-01SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
10,000
0.0099%
$32.49$324,9000%
2024-06-03SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
10,000
0.0098%
$32.00$320,000+32.86%
2024-05-28SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
30,000
0.0292%
$32.00$960,000+23.66%
2023-12-22SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
10,000
0.0095%
$32.00$320,000-7.23%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.